Literature DB >> 26183983

Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.

Sunil Dogra1, Krupashankar D S2, Leelavathy Budamakuntla3, C R Srinivas4, Uday Khopkar5, Sandesh Gupta6, Narendra Shetty7, Dasiga Venkata Subrahmanya Pratap8, M G Gopal9, T Narayana Rao10, Vijay Garg11, T K Sumathy12, Abir Saraswat13, Ramesh Bhat14, Mahendra Kura15, Neeraj Pandey16, Radha Shah17, Kotla Sai Krishna18, Dalavai Padmaja19, G Manmohan20, Ramakrishnan M S21, Abhijit Barve22, Enrique Montero23.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26183983     DOI： 10.1016/j.jaad.2015.03.040

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  11 in total

Review 1.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

2.  CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal.

Authors:  Gospel Enyindah-Asonye; Yan Li; Wei Xin; Nora G Singer; Neetu Gupta; John Fung; Feng Lin
Journal:  J Biol Chem       Date:  2016-12-01       Impact factor: 5.157

3.  Safety and Efficacy of Itolizumab in the Treatment of Psoriasis: A Case Series of 20 Patients.

Authors:  Anchala Parthasaradhi
Journal:  J Clin Diagn Res       Date:  2016-11-01

Review 4.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2022-05-23

5.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

6.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Sivem Afach; Liz Doney; Corinna Dressler; Camille Hua; Canelle Mazaud; Céline Phan; Carolyn Hughes; Dru Riddle; Luigi Naldi; Ignacio Garcia-Doval; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-09

Review 7.  Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.

Authors:  Sarah Elyoussfi; Benjamin J Thomas; Coziana Ciurtin
Journal:  Rheumatol Int       Date:  2016-02-18       Impact factor: 2.631

8.  Itolizumab in Psoriasis.

Authors:  Ankita Srivastava
Journal:  Indian J Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.494

9.  A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19.

Authors:  Suresh Kumar; Rosemarie De Souza; Milind Nadkar; Randeep Guleria; Anjan Trikha; Shashank R Joshi; Subramanian Loganathan; Sivakumar Vaidyanathan; Ashwani Marwah; Sandeep N Athalye
Journal:  Expert Opin Biol Ther       Date:  2021-04-09       Impact factor: 4.388

10.  A Real-World Study to Assess the Effectiveness of Itolizumab in Patients with Chronic Plaque Psoriasis.

Authors:  Anchala Parthasaradhi; Vinay Singh; S G Parasramani; Nishi Yadav; D S Krupashankar; Manish Soni; Rakesh Bansal
Journal:  Indian Dermatol Online J       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.